Pain News and Research

Latest Pain News and Research

First-quarter fiscal 2010 results announced by China Aoxing Pharmaceutical

China Aoxing Pharmaceutical Company, Inc., a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced financial and operational results for the three month ended September 30, 2009, or the first quarter of fiscal year 2010.

24 Nov 2009

Insurers under fire for denials of care, inadequate coverage

When people talk about revamping the health care system, among the often-mentioned reasons for change are unfair denials of care by insurance companies and medical debt, both of which are in the news today.

24 Nov 2009

Fourth-quarter and full year fiscal 2009 results announced by AVANIR Pharmaceuticals

AVANIR Pharmaceuticals, Inc. today reported unaudited financial results for the three and twelve months ended September 30, 2009.

24 Nov 2009

DJO's new Moveo XP Rehabilitation Platform granted U.S. patent

DJO Incorporated, a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced that its Chattanooga division was issued U.S. Patent No. 7597656 for Chattanooga’s new Moveo XP Rehabilitation Platform. The Moveo XP is the first product of its kind, allowing patients who are incapable of supporting full body weight to participate in graded weight-bearing activity at an earlier stage in their physical rehabilitation.

24 Nov 2009

Pain assessment and management may improve patient outcomes and lead to shorter ICU stays

A large study of more than 1,300 patients has provided evidence that increased attention to pain assessment in mechanically ventilated patients in the intensive care unit (ICU) may improve patient outcomes and lead to shorter ICU stays.

24 Nov 2009

Emergency dental solutions can ease pain and discomfort, according to survey

Nearly every household has some sort of a first aid kit filled with bandages, antiseptic, ointments and the like. But how many people plan ahead for dental emergencies?

24 Nov 2009

Study reveals high levels of cardiac biomarkers in the blood of heart attack patients

Many heart attack patients have high levels of cardiac biomarkers in the blood for several months after leaving the hospital, with more shortness of breath and chest pain, according to a Henry Ford Hospital study.

24 Nov 2009

Minimally invasive procedure relieves chronic back pain for retired school teacher

Carole Riggs, a retired teacher and school principal, points to her work during one Christmas vacation - bending, twisting and sitting on the floor to create games and teaching aids - as the primary culprit behind many years of back pain.

24 Nov 2009

Breast cancer patients treated with chemotherapy drug Taxol more likely to develop chronic neuropathic pain

Breast cancer patients treated with the chemotherapy drug Taxol (paclitaxel) are more likely to develop chronic neuropathic pain, according to research published in The Journal of Pain, the peer review publication of the American Pain Society.

24 Nov 2009

Researchers find causes for patellofemoral pain syndrome

From professional athletes to weekend warriors, the condition known as "runner's knee" is a painful and potentially debilitating injury suffered by millions of people - although until now, it has been unclear just what causes it.

24 Nov 2009

Custom Spine launches two new innovative spine systems at NASS annual meeting

Custom Spine, a company dedicated to offering advanced spinal solutions, launched two new innovative spine systems at the North American Spine Society's (NASS) annual meeting being held in San Francisco.

24 Nov 2009

Lysteda tablets to treat menorrhagia approved by the FDA

The U.S. Food and Drug Administration today approved Lysteda tablets (tranexamic acid), the first non-hormonal product cleared to treat heavy menstrual bleeding (menorrhagia). Lysteda works by stabilizing a protein that helps blood to clot.

24 Nov 2009

Neuromed discusses Exalgo NDA application with the FDA

Covidien today announced that on November 13, 2009, representatives of Neuromed discussed the pending New Drug Application (NDA) for the product candidate ExalgoTM (hydromorphone HCl extended release) tablets with staff from the United States Food and Drug Administration (FDA). Mallinckrodt Inc., a Covidien company, obtained the commercial rights to Exalgo in the United States from Neuromed Development Inc., a subsidiary of Neuromed Pharmaceuticals Ltd., in June 2009.

24 Nov 2009

New initiative launched to take care of patients with sickle cell disease

The Medical College of Georgia is leading an initiative that could result in a paradigm shift in the care of patients with sickle cell disease.

23 Nov 2009

Caldolor Injection effective in treating fever in hospitalized burn patients

Cumberland Pharmaceuticals Inc. today announced positive new top-line results from a study evaluating the safety and efficacy of Caldolor (ibuprofen) Injection in treating fever in hospitalized burn patients.

23 Nov 2009

Cook Medical unveils its uterine manipulator/injectors at 38th Global Congress of Minimally Invasive Gynecology

Laparoscopic surgeons received their first glimpse of Cook Medical’s uterine manipulator/injectors (UMI) last week at the 38th Global Congress of Minimally Invasive Gynecology, sponsored by the American Association of Gynecologic Laparoscopists (AAGL).

23 Nov 2009

Lannett CEO to participate in NYSE opening bell ringing ceremony

Lannett Company, Inc. (NYSE AMEX: LCI) today announced that President and Chief Executive Officer Arthur Bedrosian will ring the opening bell at the New York Stock Exchange at 9:30 a.m. Eastern on Monday, November 23, 2009.

23 Nov 2009

NAPRELAN Dose Card launched by Victory Pharma

Victory Pharma, Inc. ("Victory") announced today the launch of NAPRELAN® Dose Card, a further extension of Victory's NAPRELAN franchise.

23 Nov 2009

Most Canadians hope OAB symptoms will go away

A recent poll conducted by Leger Marketing, on behalf of the Powder Room - a national education program for those with overactive bladder (OAB) - asked 1,500 Canadians about their bladder health. The findings revealed that although people are experiencing OAB symptoms, most are choosing not to seek medical attention - perhaps assuming the frustrating and embarrassing symptoms will go away, or that they will just have to live with them.

23 Nov 2009

100th patient enrolled in Atrium Medical's iCAST Atrium Registry Ultrasound Study

Atrium Medical Corporation announced that the 100th patient was enrolled in the iCAST™ Atrium Registry Ultrasound Study (iCARUS). The iCARUS study is a prospective, multi-center clinical trial studying the safety and efficacy of the Atrium iCAST™ Balloon Expandable Covered Stent in patients with occlusive disease in the iliac artery.

23 Nov 2009